Elanco Wins USDA Approval for TruCan Ultra Lyme-L4 Vaccine
INDIANAPOLIS, June 15, 2026 Elanco Animal Health Incorporated has announced that the U.S. Department of Agriculture (USDA) has approved...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
INDIANAPOLIS, June 15, 2026 Elanco Animal Health Incorporated has announced that the U.S. Department of Agriculture (USDA) has approved...
REDWOOD CITY, Calif., May 18, 2026 Galvanize Therapeutics has announced that the U.S. Food and Drug Administration (FDA) granted...
OVERLAND PARK, Kan., May 19, 2026 Dechra has announced that the U.S. Food and Drug Administration (FDA) approved CosACTHen®...
RAHWAY, N.J., September 26, 2025 – Merck Animal Health, known as MSD Animal Health outside the U.S. and Canada...
